S-1 and raltitrexed for patients with metastatic colorectal cancer after failure to fluoropyrimidine, irinotecan and oxaliplatin.

ABSTRACT: Interventions: experimental group:S-1 and raltitrexed Primary outcome(s): progression - free survival;tumor objective response rate Study Design: Case series

DISEASE(S): Colorectal Cancer

PROVIDER: 2670639 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR